Application of Visual Laryngeal Mask Airway Combined With Endotracheal Intubation in General Anesthesia

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04719767
Collaborator
(none)
50
2
16.9

Study Details

Study Description

Brief Summary

To study the advantages of visual laryngeal mask combined with endotracheal intubation in general anesthesia surgery, we compared intubation time, intubation times and intubation success rate of endotracheal intubation through laryngeal mask airway under visual and non-visual conditions, at the same time, the laryngeal mask displacement rate, volume of secretion in airway, the incidence of laryngeal spasm, the incidence and severity of postoperative oropharyngeal pain were also compared between two groups.

Condition or Disease Intervention/Treatment Phase
  • Device: visual laryngeal mask
N/A

Detailed Description

After entering the operating room, the patient received routine general anaesthesia monitoring, and anesthesia induction was conducted after three-party verification. Propofol (plasma target-controlled concentration: 3.5ug/ mL), midazolam (0.05mg/kg), fentanyl (2ug/kg) and rocuronium (0.6mg/kg) were used to induce the drugs.

After anesthesia induction, visual laryngeal mask airway was placed in the visual group and endotracheal intubation was guided under visual conditions. In the non-visual group, after judging the position of laryngeal mask by clinical experience, endotracheal intubation was inserted blindly. Selection of laryngeal mask airway (LMA) model based on: the ideal body weight of the patient, 3 was selected for the body weight of 30-50kg, 4 for the body weight of 50-70kg and 5 for the body weight > 70kg. The endotracheal tube intubation time, intubation times and intubation success rate of the two groups were recorded.

During the operation, propofol and fentanyl are used for anesthesia maintenance, and the anesthesiologist adjusts the anesthesia depth according to his/her own experience. Ten minutes before the end of the operation, endotracheal intubation was removed and the laryngeal mask airway was retained. The displacement rate of the laryngeal mask airway, the volume of secretion in airway and the incidence of laryngeal spasm were compared between the two groups.

After the surgery, the residual muscle relaxation was antagonized, and the laryngeal mask was removed after the patient regained consciousness and reached the extubation criteria. The hemodynamic parameters and the severity of cough during laryngeal mask airway removal were recorded. The incidence and severity of oropharyngeal pain, oropharyngeal numbness, hoarseness, nausea, and vomiting were assessed immediately after the patient woke up and was followed up before leaving the recovery room and on the first day after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description:
The patients, surgeons and the ones who collect data will be masked.
Primary Purpose:
Treatment
Official Title:
Application of Visual Laryngeal Mask Airway Combined With Endotracheal Intubation in Non-head and Neck Surgery Under General Anesthesia
Anticipated Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: visual

In the visual group, a visual laryngeal mask was placed and endotracheal intubation was guided under visual conditions. The endotracheal tube was removed 10 minutes before the end of the operation, and the laryngeal mask was retained.

Device: visual laryngeal mask
After anesthesia induction, visual laryngeal mask airway was placed in the visual group and tracheal intubation was guided under visual conditions. In the non-visual group, laryngeal mask airway was inserted, after clinical judgment of good counterpoint of the laryngeal mask, endotracheal intubation was inserted blindly through LMA. Selection of laryngeal mask airway (LMA) model: the ideal body weight of the patient was calculated.

No Intervention: Non-visual

In the non-visual group, laryngeal mask airway was inserted. After clinical judgment of good counterpoint, endotracheal intubation was inserted blindly through LMA. Endotracheal intubation was removed 10 minutes before the end of the operation, and the laryngeal mask airway was retained.

Outcome Measures

Primary Outcome Measures

  1. Intubation time (second) [intraoperative]

    Compare the time of endotracheal intubation through laryngeal mask airway under visual and non-visual conditions

Secondary Outcome Measures

  1. Success rate of the endotracheal intubation (%) [intraoperative]

    Compare success rate of endotracheal intubation through laryngeal mask airway under visual and non-visual conditions

  2. Displacement rate of the laryngeal mask airway (%) [Immediately after operation]

    Compare displacement rate of the laryngeal mask airway after tracheal intubation removal under visual and non-visual conditions

  3. Incidence of oropharyngeal pain as assessed by the VAS [postoperative one day]

    On the first day after operation, the patients were asked to score the oropharyngeal pain. Based on the distribution of pain VAS scores in postsurgical patients, the following cut points on the pain VAS have been recommended. No pain (0 -4 mm) Mild pain (5-44 mm) Moderate pain (45-74 mm) Severe pain (75-100 mm) The significance of the Visual Analog Scale.

  4. Incidence and severity of hoarseness as assessed by a numerical scale [postoperative one day]

    Normal = 1, weakened or hoarse = 2, unable to pronounce = 3

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 18-70

  • American Society of Anesthesiologist physical status (ASA) Ⅰ-II

  • Undergoing non-head and neck surgery under general anesthesia with endotracheal intubation

  • Sign the informed consent voluntarily;

Exclusion Criteria:
  • Not willing to participate in the study or not able to sign the informed consent

  • American Society of Anesthesiologist physical status (ASA) Ⅲ-Ⅳ

  • Weight <30kg or BMI>40 kg/m2

  • High risk of reflux aspiration

  • Combined with severe respiratory disease

  • Combined oropharyngeal lesions affect the laryngeal mask insertion

  • Oropharyngeal pain in the last two weeks.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Study Director: Yuguang Huang, M.D., Peking Union Medical College Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Xia Ruan, Attending doctor of the Department of Anesthesiology, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT04719767
Other Study ID Numbers:
  • PUMCH-rx
First Posted:
Jan 22, 2021
Last Update Posted:
Jan 25, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 25, 2021